Search Results

There are 7465702 results for: content related to: Subject Index

  1. Growth Factor Function in the Development and Maintenance of Midbrain Dopaminergic Neurons: Concepts, Facts and Prospects for TGF-β

    Ciba Foundation Symposium 196 - Growth Factors as Drugs for Neurological and Sensory Disorders

    Klaus Unsicker, Clemens Suter-Crazzalora, Kerstin Krieglstein, Pages: 70–84, 2007

    Published Online : 28 SEP 2007, DOI: 10.1002/9780470514863.ch6

  2. Age-related decline in the dopaminergic nigrostriatal system: The oxidative hypothesis and protective strategies

    Annals of Neurology

    Volume 32, Issue S1, 1992, Pages: S133–S136, Dr. David L Felten, Suzanne Y. Felten, Kathy Steece-Collier, Isao Date and James A. Clemenst

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410320723

  3. Cell Transplantation and Gene Therapy in Parkinson's Disease

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 1, January/February 2011, Pages: 126–158, Dustin R. Wakeman, Hemraj B. Dodiya and Jeffrey H. Kordower

    Version of Record online : 21 JAN 2011, DOI: 10.1002/msj.20233

  4. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice

    European Journal of Neuroscience

    Volume 23, Issue 6, March 2006, Pages: 1671–1675, S. Zechel, J. Jarosik, I. Kiprianova, A. Schober, K. Unsicker and O. von Bohlen und Halbach

    Version of Record online : 16 MAR 2006, DOI: 10.1111/j.1460-9568.2006.04700.x

  5. Anatomical and functional reconstruction of the nigrostriatal system in vitro: Selective innervation of the striatum by dopaminergic neurons

    Journal of Neuroscience Research

    Volume 58, Issue 4, 15 November 1999, Pages: 553–566, H. Becq, O. Bosler, M. Geffard, A. Enjalbert and J.P. Herman

    Version of Record online : 21 OCT 1999, DOI: 10.1002/(SICI)1097-4547(19991115)58:4<553::AID-JNR8>3.0.CO;2-8

  6. Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes


    Volume 21, Issue 2, October 1997, Pages: 204–216, Mati Revuelta, José L. Venero, Alberto Machado and Josefina Cano

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-1136(199710)21:2<204::AID-GLIA4>3.0.CO;2-6

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  8. Monitoring Dopamine in the Mesocorticolimbic and Nigrostriatal Systems by Microdialysis: Relevance for Mood Disorders and Parkinson's Disease

    Applications of Microdialysis in Pharmaceutical Science

    Giuseppe Di Giovanni, Massimo Pierucci, Vincenzo Di Matteo, Pages: 93–150, 2011

    Published Online : 25 JUL 2011, DOI: 10.1002/9781118011294.ch4

  9. Long-Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat Brain

    Journal of Neurochemistry

    Volume 64, Issue 4, April 1995, Pages: 1669–1679, Véronique Blanchard, Muriel Chritin, Sheela Vyas, Marc Savasta, Claude Feuerstein, Yves Agid, France Javoy-Agid and Rita Raisman-Vozari

    Version of Record online : 23 NOV 2002, DOI: 10.1046/j.1471-4159.1995.64041669.x

  10. You have free access to this content
    Time Course Changes in the Dopaminergic Nigrostriatal System Following Transection of the Medial Forebrain Bundle: Detection of Oxidatively Modified Proteins in Substantia Nigra

    Journal of Neurochemistry

    Volume 68, Issue 6, June 1997, Pages: 2458–2468, José L. Venero, Mati Revuelta, Josefina Cano and Alberto Machado

    Version of Record online : 18 NOV 2002, DOI: 10.1046/j.1471-4159.1997.68062458.x

  11. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  12. The nigrostriatal dopamine system of aging GFRα-1 heterozygous mice: neurochemistry, morphology and behavior

    European Journal of Neuroscience

    Volume 28, Issue 8, October 2008, Pages: 1557–1568, Vandana Zaman, Heather A. Boger, Ann-Charlotte Granholm, Baerbel Rohrer, Alfred Moore, Mona Buhusi, Greg A. Gerhardt, Barry J. Hoffer and Lawrence D. Middaugh

    Version of Record online : 7 OCT 2008, DOI: 10.1111/j.1460-9568.2008.06456.x

  13. FGF-2 and S100β immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system

    Cell Biology International

    Volume 28, Issue 12, December 2004, Pages: 849–861, G. Chadi and V.C. Gomide

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2004.08.005

  14. Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease


    Volume 62, Issue 12, December 2008, Pages: 920–926, Yasushi Ishida, Keiichi Kawai, Yasuhiro Magata, Kosuke Ebihara, Ryuichiro Takeda, Hiroshi Abe, Mitsuyoshi Yoshimoto, Hiroyuki Hashiguchi, Kei Odagiri, Hisae Matsuo and Toshikazu Nishimori

    Version of Record online : 15 SEP 2008, DOI: 10.1002/syn.20558

  15. Fibroblast growth factor 2 regulates adequate nigrostriatal pathway formation in mice

    Journal of Comparative Neurology

    Volume 520, Issue 17, 1 December 2012, Pages: 3949–3961, Olga Baron, Andreas Ratzka and Claudia Grothe

    Version of Record online : 1 OCT 2012, DOI: 10.1002/cne.23138

  16. You have free access to this content
    Ictal involvement of the nigrostriatal system in subtle seizures of ring chromosome 20 epilepsy


    Volume 53, Issue 8, August 2012, Pages: e156–e160, Stefano Meletti, Aglaia Vignoli, Francesca Benuzzi, Pietro Avanzini, Andrea Ruggieri, Matteo Pugnaghi, Paolo Nichelli and Maria Paola Canevini

    Version of Record online : 27 JUN 2012, DOI: 10.1111/j.1528-1167.2012.03568.x

  17. Intraventricular infusion of basic fibroblast growth factor (bFGF) in the MPTP-treated common marmoset


    Volume 23, Issue 3, July 1996, Pages: 192–200, R.K.B. Pearce, P. Collins, P. Jenner, C. Emmett and C.D. Marsden

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199607)23:3<192::AID-SYN8>3.0.CO;2-3

  18. A tale on animal models of Parkinson's disease

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 993–1002, Erwan Bezard and Serge Przedborski

    Version of Record online : 27 MAY 2011, DOI: 10.1002/mds.23696

  19. Nicotine as a potential neuroprotective agent for Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 947–957, Maryka Quik, Xiomara A. Perez and Tanuja Bordia

    Version of Record online : 12 JUN 2012, DOI: 10.1002/mds.25028

  20. Behavioural Effects of Substance P through Dopaminergic Pathways in the Brain

    Ciba Foundation Symposium 91 - Substance P in the Nervous System

    Ruth Porter, Maeve O'Connor, Pages: 307–337, 2008

    Published Online : 30 MAY 2008, DOI: 10.1002/9780470720738.ch18